Fourth webinar in the series: From research and innovation to development: how to plan and execute translational projects in life sciences, this edition looks more closely at IP protection strategies for translational research.
It focuses on intellectual property (IP) and spin-out strategies in the human healthcare sector. A well-designed IP strategy, tailored to the type of innovation, is crucial for the long-term success of university spin-outs.
Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements. They’ll share insights on the essential components of an IP strategy for the healthcare sector and discuss how these components vary based on the type of innovation—whether in biotech, pharma, or digital health—and the intended business model.
I strongly recommend the course, even if you are not going to set-up an office but you are part of the team that wants to change or improve how technology transfer is done at your institution.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
One very long and hard day, but very useful for my work in TTO.
Petr Kubečka
Palacký University Olomouc, Czech Republic
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.
Ram Siddappa
Erasmus MC, Netherlands
Working and Learning with old and new friends – best way to do it!
Sara Matt-Leubner
University of Innsbruck, Austria
Join our newsletter and get the latest news